MedTrace Logo

Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum

NCT02641691 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-02-18

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to look at how tumors responds to a short course of radiation (5 days) followed by 8 cycles of chemotherapy.

Conditions

  • Cancer of Rectum
  • Cancer of the Rectum
  • Neoplasm, Rectum
  • Rectal Cancer
  • Rectum Cancer
  • Rectum Neoplasms
  • Adenocarcinoma of the Rectum

Interventions

RADIATION

Radiation

DRUG

Oxaliplatin

DRUG

Leucovorin

DRUG

Fluorouracil

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Hyun Kim, M.D. · Washington University School of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-27
Primary Completion
2020-02-04
Completion
2020-03-29
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02641691 on ClinicalTrials.gov